MDT Stock Chart & Fundamental Analysis

Interactive Chart

About Medtronic PLC

Name

Medtronic PLC

CEO

Geoffrey Straub Martha

Website

www.medtronic.com

Industry

Healthcare

Year Founded

1949

Employees

95,000

Medtronic plc (NYSE: MDT) makes medical technology used in cardiac care, surgery, imaging, spine, and diabetes management, and it operates across the healthcare sector as a global device maker with products used by hospitals, clinicians, physicians, and patients worldwide. In FY2026, the company generated $36.4 billion in revenue.

Analyst Ratings

Consensus Recommendation

Buy4

Hold2

Sell1

Fundamentals & Financials

Revenue (TTM)

$36.3B

Net Income (TTM)

$4.8B

EPS (TTM)

$3.75

ROA (TTM)

5.16%

Current Ratio

2.13

Dividend Yield

0.85%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q4 FY2026	Q3 FY2026	Q2 FY2026
Revenue	$9,807M	$9,018M	$8,961M
Cost of Sales	$2,367M	$3,166M	$3,556M
Gross Profit	$7,441M	$5,851M	$5,405M
Operating Income	$1,564M	$1,773M	$1,685M
Net Income	$1,243M	$1,143M	$1,374M
EPS	$0.98	$0.89	$1.07

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Medtronic PLC's Technical Indicators Summary

MDT registers a buy bias as price has moved above short- and medium-term averages while remaining below the long-term 100/200-day levels, signaling a multi-timeframe dichotomy. Momentum metrics—a strong CCI and a modestly positive MACD—support upside momentum, while RSI sits in neutral territory and ADX near the high teens implies a weak trend. ATR indicates moderate volatility and OBV is supportive, and the classic pivot near 79 offers nearby support. Technical takeaway: Buy — short-term strength is evident but longer-term moving averages temper the outlook.

Buy

4 signals

Neutral

2 signals

Sell

1 signal

Overall: Bullish57% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	60.13	Neutral	RSI (60.13) is neutral.
Stochastic %K (14, 3, 3)	47.65	Neutral	Stochastic (47.65) is neutral.
CCI (20)	138.74	Buy	CCI (138.74) > 100, indicating strong upward momentum.
WPR (14)	-2.11	Sell	Williams %R (-2.11) > -20, indicating overbought.
Momentum (10)	5.05	Buy	Momentum (5.05) is positive.
MFI	54.81	Neutral	MFI (54.81) is neutral.
MACD Level (12, 26)	0.42	Buy	Confirmed uptrend: MACD (0.42) is positive and above its signal line (0.25).
Bollinger Bands	$77.97 - $82.96	Sell	Price ($83.19) is above the upper band ($82.96).
ATR (14)	$2.11 (2.54%)	Neutral	Moderate Volatility (2.54%).
ADX (14)	18.20	Neutral	Weak or consolidating trend (ADX < 25). ADX(18.20), +DI(27.78), -DI(21.24)
OBV	-137,626,396	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(-137,626,396), 20D-SMA-OBV(-157,611,909)
Classic Pivot Point	$79.36	Buy	Price ($83.19) has broken above resistance R1 ($80.12) — bullish breakout potential.
Fibonacci Pivot Point	$79.36	Buy	Price ($83.19) has broken above resistance R1 ($80.00) — bullish breakout potential.
Simple Moving Averages	$79.05 - $91.33(5 indicators)	Buy	SMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$79.96 - $88.26(5 indicators)	Buy	EMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day concluded with MDT maintaining a pronounced 5.03% gain. The session wrapped with a strong sector advance of 2.65%, creating a supportive backdrop for MDT. MDT climbs as a buoyant medtech sector supports it, with cyberattack notification updates acting as a company-specific driver.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+4.31%

52-Week Position

Lower range

29.9%

Updated: July 2, 2026 at 20:15 UTC